GGrantIndex
← Search

PHASE I STUDY OF ERBITUX (CETUXIMAB) IN PED SUBJ WITH SOLID TUMORS CA225-085

$9,058M01FY2007RRNIH

University Of Florida, Gainesville FL

Investigators

Linked publications & trials

View original record on NIH RePORTER →